BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11939740)

  • 1. The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
    West RB; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2002 Apr; 117(4):636-43. PubMed ID: 11939740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
    Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous presentation of follicular lymphomas.
    Franco R; Fernández-Vázquez A; Mollejo M; Cruz MA; Camacho FI; García JF; Navarrete M; Piris MA
    Mod Pathol; 2001 Sep; 14(9):913-9. PubMed ID: 11557789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD23 expression in mediastinal large B-cell lymphomas.
    Calaminici M; Piper K; Lee AM; Norton AJ
    Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
    Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
    J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.
    Cornfield DB; Mitchell DM; Almasri NM; Anderson JB; Ahrens KP; Dooley EO; Braylan RC
    Am J Clin Pathol; 2000 Aug; 114(2):258-63. PubMed ID: 10941341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5+ follicular lymphoma: a clinicopathologic study of three cases.
    Barry TS; Jaffe ES; Kingma DW; Martin AW; Sorbara L; Raffeld M; Pittaluga S
    Am J Clin Pathol; 2002 Oct; 118(4):589-98. PubMed ID: 12375647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow.
    Cook JR; Craig FE; Swerdlow SH
    Am J Clin Pathol; 2003 Jan; 119(1):145-51. PubMed ID: 12520710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staining for Bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies.
    Ben-Ezra JM; King BE; Harris AC; Todd WM; Kornstein MJ
    Mod Pathol; 1994 Jun; 7(5):560-4. PubMed ID: 7937722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous B cell processes with nodular pattern].
    Chirife AM; Bilbao ER; Giménez L; Marino L
    Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.
    Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC
    Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
    Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
    Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies.
    Fakan F; Skálová A; Kuntscherová J
    Gen Diagn Pathol; 1996 May; 141(5-6):359-63. PubMed ID: 8780936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma.
    Chetty R; Echezarreta G; Comley M; Gatter K
    J Clin Pathol; 1995 Nov; 48(11):1035-8. PubMed ID: 8543627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue.
    Kubic VL; Brunning RD
    Mod Pathol; 1989 Nov; 2(6):618-29. PubMed ID: 2587569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DO. A useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry.
    Chen X; Jensen PE; Li S
    Am J Clin Pathol; 2003 Jun; 119(6):842-51. PubMed ID: 12817432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.